What happens when pharma and flow cores face the same challenge — doing more with less?​ Join Ryan Duggan (AbbVie) and David ...
SAN ANTONIO, October 20, 2025--bioAffinity Technologies will present research related to its noninvasive CyPath Lung test for ...
Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...
The International Liaison Committee on Resuscitation conducts continuous reviews of new, peer-reviewed, published first aid ...